Therapeutics About Us ELFTest Liver Disease News Home
ELF Testing


Sample preparation

Registration Form


Analysis Request Form


Enhanced Liver Fibrosis Test (ELF™ Test) 

Measuring fibrosis using serum markers

The Enhanced Liver Fibrosis Test (ELF™) is a simple, accurate blood test for measuring liver damage (known as 'fibrosis').

Fibrotic damage to the liver results from many chronic conditions, including alcoholic liver disease, primary biliary cirrhosis and hepatitis. It is also caused by lifestyle choices, such as regular excessive drinking, binge drinking or eating an unhealthy diet.

Liver fibrosis remains unseen and may be symptomless for many years. The ELF™ Test is able to detect fibrosis at all stages of development, even in patients without symptoms of damage.

Unique to iQur, the  ELF™ Test offers a quick and straightforward method of providing valuable information. It can be used

      • repeatedly,
      • with minimal patient discomfort,
      • to identify significant liver disease,
      • to monitor disease progression and response to therapy.

How to obtain an ELF™ Test
Worried about your liver? You don't have to go to hospital to experience the peace of mind gained by having an ELF™ Test. iQur is now able to offer this service to everyone.

If you are a patient...
The ELF™ Test is a recent development so your GP may not yet have heard of it. It may be helpful to print off the information on the test from this website and take it to your next appointment to help explain your concerns and desire to have this test. Your GP will need to take a small blood sample from you which will be sent off to our laboratory for analysis. The results will be ready within a few days and your GP will inform you at your next appointment or by telephone (depending on local practice). Please note - you are likely to be charged for having this test.

If you are a GP...
The ELF™ Test requires a plain or SST blood sample to be drawn. This must be centrifuged and the serum separated. If you are unable to separate serum at your practice, contact your local pathology laboratory which may offer a separation service. The serum sample should be sent to our laboratory for analysis, accompanied by an analysis request form (see below). Please click HERE for full sample collection instructions.

The ELF™ Test is chargeable and you need to register your contact details, which will be used for invoicing. Results are returned to you by fax or email to a secure address, as preferred, in addition to a full report by post. Please call or email for further information or pricing.

If you are a hospital clinician...
Take a plain or SST blood sample from the patient according to the full sample collection instructions (click HERE). The sample must be separated and sent to our laboratory, accompanied by an analysis request form. The ELF™ Test is chargeable and you need to register your contact details, which will be used for invoicing. Results are returned to you by fax or email to a secure address, as preferred, in addition to a full report by post. Please call or email for further information or pricing.

  •   DOWNLOAD A REGISTRATION FORM HERE
  •   DOWNLOAD AN ANALYSIS REQUEST FORM HERE

Need help?
If you experience any difficulties in locating an ELF™ Test provider, or would like further information about any aspect of this service, please contact us at richard.cross@iqur.com or by telephone, +44(0)207 679 9326.

How does it work?
ELFTM combines three direct serum markers that have been shown to correlate to the level of liver fibrosis assessed by liver biopsy: hyaluronic acid, TIMP-1 and PIIINP.  The combined measurement of these markers indicates the degree of fibrotic damage. ELFTM has been developed following intensive research by the European Liver Fibrosis Group in collaboration with Siemens Medical Solutions Diagnostics and the University of Southampton.

Designed to complement liver biopsies, ELF™ is CE marked and is available as a fully approved IVD test or for research use.


Home | Therapeutics | ELF Testing | About Us | About Liver Disease | News | Contact Us